Literature DB >> 30396919

Collision Tumors of the Gastrointestinal Tract: A Systematic Review of the Literature.

Dimitrios Schizas1, Ioannis Katsaros1, Adamantios Michalinos1, Christos Damaskos2, Nikolaos Garmpis3, Vasileia Ntomi4, George Agrogiannis5, Spyridon Stergiopoulos6, Alexandra K Tsaroucha7.   

Abstract

BACKGROUND/AIM: Collision tumors are rare neoplasms which consist of two or more distinct neoplasms that develop adjacent to one another and coexist with no or minimal intermingling between them. Their diagnosis is often incidental and their behavior remains widely unknown. Several theories have been proposed regarding their pathogenesis. The objective of this study was the evaluation of current evidence on collision tumors of the gastrointestinal tract regarding their pathology, biological behavior and treatment approach.
MATERIALS AND METHODS: The PubMed and Cochrane bibliographical databases were searched from January 1997 to July 2018 (last search: July 5th, 2018) for studies reporting on collision tumors of the gastrointestinal tract that also included a therapeutic approach.
RESULTS: Forty-seven studies reporting on collision tumors of the gastrointestinal tract were identified. They reported collectively on 53 cases (43 males, 10 females) with collision tumors of the esophagus, stomach, small intestine and large intestine. The vast majority (96.2%) of tumors consisted of two distinct histological components and only two cases involved a greater number of histological subtypes. Fifty-one patients underwent a surgical or endoscopic tumor resection, accompanied in 22 cases by adjuvant or neoadjuvant therapy. The remaining two patients underwent palliative operations. In total, three patients experienced immediate postoperative complications.
CONCLUSION: Collision tumors of the gastrointestinal tract, despite their rare nature, constitute a quite interesting field of study. This review offers a thorough insight into the clinicopathological characteristics and biological behavior of these rare tumors. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Collision tumors; esophagus; gastrointestinal tract; large intestine; rare tumors; small intestine; stomach; systematic review

Mesh:

Year:  2018        PMID: 30396919     DOI: 10.21873/anticanres.12955

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Polymorphous Adenocarcinoma, Low Grade Variant, Colliding with a Neurofibroma.

Authors:  Nikolaos G Katsoulas; Konstantinos I Tosios; Hannah Afwerke Lynch; Rachel Uppgaard; Ioannis G Koutlas
Journal:  Head Neck Pathol       Date:  2021-09-01

2.  Collision tumor at the rectum consisting of a neuroendocrine carcinoma and adenocarcinoma: A case report.

Authors:  Jaspreet Nannar; Alyssa Anciro; Atul K Nanda
Journal:  Ann Med Surg (Lond)       Date:  2022-05-10

3.  A Potential Concomitant Sellar Embryonic Remnant-Associated Collision Tumor: Systematic Review.

Authors:  Mingdong Wang; Qianhui Fu; Mingjing Song; Zongmao Zhao; Renzhi Wang; John Zhang; Wenbin Ma; Zhanxiang Wang
Journal:  Front Oncol       Date:  2021-04-29       Impact factor: 6.244

4.  Collision Tumor of the Stomach.

Authors:  Kimitoshi Kubo; Ryo Takahashi; Noriko Kimura; Norishige Maiya; Soichiro Matsuda; Momoko Tsuda; Takeshi Mizushima; Masanori Ohara; Mototsugu Kato
Journal:  Case Rep Gastroenterol       Date:  2021-03-18

Review 5.  Composite intestinal adenoma-microcarcinoid: An update and literature review.

Authors:  Zhi-Yan Fu; Michel Kmeid; Mahmoud Aldyab; Stephen M Lagana; Hwajeong Lee
Journal:  World J Gastrointest Endosc       Date:  2021-12-16

6.  Mixed epithelial endocrine neoplasms of the colon and rectum - An evolution over time: A systematic review.

Authors:  Rani Kanthan; Suresh Tharmaradinam; Tehmina Asif; Shahid Ahmed; Selliah C Kanthan
Journal:  World J Gastroenterol       Date:  2020-09-14       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.